Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
40 participants
INTERVENTIONAL
2014-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Peppermint oil will be used for nausea/vomiting and lavender oil will be used for anxiety. This study will involve administration of aromatherapy to a convenience sample of patients, who will then be asked to complete a brief questionnaire. The questionnaire will involve a simple likert scale to measure efficacy (in the opinion of the patient) and simple multiple-choice questions to determine patients' likeliness to use aromatherapy again.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Outpatient Oncology Aromatherapy for Symptom Management
NCT04449315
The Effects of Inhaled Aromatherapy on Chemotherapy Induced Nausea (CINV) and Vomiting
NCT04478630
Aromatherapy Essential Oils to Manage Anxiety and Nausea in Cancer Patients Receiving Infusion in the Ambulatory Setting
NCT07126301
Aromatherapy for Integrated Cancer Care
NCT03449511
Aromatherapy and Essential Oils in Improving Insomnia and Other Symptoms in Patients With Newly Diagnosed Acute Leukemia Undergoing Chemotherapy
NCT02445378
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Peppermint and Lavender Essential Oils
Peppermint and Lavender Essential Oils
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Peppermint and Lavender Essential Oils
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 18 years or greater.
* Able to understand and speak English.
* Women of non-childbearing potential or with childbearing potential with a negative pregnancy test documented during the hospital stay.
* Able to understand concept of aromatherapy for treatment of distressing symptoms.
Exclusion Criteria
* Non-English speaking patients.
* Under the age of 18.
* Unable to comprehend the concept of aromatherapy.
* Severe cognitive impairment.
* Not experiencing the symptoms of nausea, vomiting or anxiety.
* Women with child-bearing potential who have not had a negative pregnancy test during the hospital stay.
* Patients with known allergy to lavender or peppermint.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Central DuPage Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mary Lyons, MSN, APN/CNS, RN-BC, ONC
Role: PRINCIPAL_INVESTIGATOR
Central DuPage Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Central DuPage Hospital
Winfield, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Mary Lyons, MSN, APN/CNS, RN-BC ONC
Role: primary
Lorraine Mack, RN
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
14-031-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.